Name: Citius Oncology, Inc. (CTOR) Balance Sheet
Creator: FinSpry

Citius Oncology Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Citius Oncology, Inc. (CTOR) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2025	Sep 2024	Sep 2023	Sep 2022
Current Assets
Cash and Cash Equivalents	3.92	0.00	0.00	0.00
Cash & Short-Term Investments	3.92	0.00	0.00	0.00
Accounts Receivable	0.00	0.00	0.00	0.00
Inventory	22.29	8.27	0.00	0.00
Other Current Assets	1.33	2.70	7.73	2.69
Total Current Assets	27.54	10.97	7.73	2.69
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	0.00	0.00
Intangible Assets	73.40	73.40	40.00	40.00
Other Non-Current Assets	0.00	73.40	0.00	0.00
Total Non-Current Assets	73.40	73.40	40.00	40.00
Total Assets	100.94	84.37	47.73	42.69
Current Liabilities
Accounts Payable	13.23	3.71	1.29	0.09
Accrued Liabilities	13.61	0.59	0.26	1.06
Other Current Liabilities	36.26	28.40	0.00	0.00
Total Current Liabilities	49.49	32.70	21.05	5.85
Non-Current Liabilities
Long-Term Debt	3.80	3.80	0.00	0.00
Deferred Tax Liabilities	2.78	1.73	1.15	0.58
Other Non-Current Liabilities	0.00	28.40	0.00	0.00
Total Non-Current Liabilities	6.59	30.13	1.15	0.58
Total Liabilities	56.08	38.23	22.20	6.42
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.01
Retained Earnings	-64.04	-39.28	-18.13	-5.43
Additional Paid-in Capital	108.90	85.41	43.66	41.69
Shares Outstanding	83.51	71.55	71.24	71.24
Total Stockholders' Equity	44.87	46.14	25.54	36.27
Total Liabilities & Equity	100.94	84.37	47.73	42.69